Skip to Content

Sonic Healthcare Ltd SHL

Morningstar Rating
A$25.01 −1.60 (6.01%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

SHL is trading at a 37% premium.
Price
A$26.61
Fair Value
A$78.00
Uncertainty
Medium
1-Star Price
A$23.30
5-Star Price
A$84.10
Economic Moat
Myrrcjs
Capital Allocation
Mdxhrwvs

Bulls Say, Bears Say

Bulls

Sonic has a leading market position in most of its geographies and as a result benefits from a cost advantage derived from scale.

Bears

Elevated covid-19 testing is not able to be maintained and acquisitive growth is becoming more expensive to achieve.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
A$26.61
Day Range
A$23.5825.17
52-Week Range
A$23.5836.40
Bid/Ask
A$24.97 / A$25.15
Market Cap
A$12.01 Bil
Volume/Avg
6.7 Mil / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
23.18
Price/Sales
1.42
Dividend Yield (Trailing)
3.94%
Dividend Yield (Forward)
3.94%
Total Yield
4.20%

Company Profile

Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand, and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S., and 35% in Europe.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Value
Total Number of Employees
41,000

Competitors

Valuation

Metric
SHL
HLS
DGX
Price/Earnings (Normalized)
23.182.5715.98
Price/Book Value
1.550.902.40
Price/Sales
1.420.471.69
Price/Cash Flow
10.412.7811.12
Price/Earnings
SHL
HLS
DGX

Financial Strength

Metric
SHL
HLS
DGX
Quick Ratio
0.780.440.78
Current Ratio
0.940.530.97
Interest Coverage
5.95−13.267.31
Quick Ratio
SHL
HLS
DGX

Profitability

Metric
SHL
HLS
DGX
Return on Assets (Normalized)
4.07%0.10%7.33%
Return on Equity (Normalized)
7.01%0.23%15.76%
Return on Invested Capital (Normalized)
4.52%2.27%9.73%
Return on Assets
SHL
HLS
DGX
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncXbznmntjzTxkr$226.7 Bil
DHR
Danaher CorpFkrlrtstbrKgdcwj$197.8 Bil
A
Agilent Technologies IncGchkqgjkzmMzkp$45.3 Bil
IDXX
IDEXX Laboratories IncPcbkbvkhKnlnyr$43.8 Bil
IQV
IQVIA Holdings IncLcjymjvmrCxsqm$41.9 Bil
MTD
Mettler-Toledo International IncCsltrncfzQzbvw$32.4 Bil
ICLR
Icon PLCLvkxtmfWtbbjw$26.0 Bil
WAT
Waters CorpMkmpxqtdtKssx$21.1 Bil
LH
Laboratory Corp of America HoldingsZpysqwvtkNmxcdx$17.4 Bil
ILMN
Illumina IncBzgbdyhjNnfnrs$17.3 Bil

Sponsor Center